Stock Price

Crypto exchange Phemex now offers 24/7 stock and metal futures, a bold move to unify markets that also navigates a complex and risky regulatory maze.

The warehouse club operator signals robust confidence with a major dividend hike and plans for four new stores, pushing its stock to near-record highs.

Amid soaring aerospace demand and strong financials, the critical component supplier will outline its tech and market strategy at its March 10 investor day.

The fintech firm is pivoting hard into digital assets, planning to mine Bitcoin Cash while launching a novel crypto life insurance business in Bermuda.

Industrial conglomerate Schouw & Co. offers a fee for bondholder consent to spin off its aquaculture giant BioMar, a move that could unlock value but alters risk.

Bitcoin Everlight's presale evokes Bitcoin's early days. We dive into whether this is a genuine revival of core ethos or a savvy marketing narrative.

As HUTCHMED prepares to unveil its 2025 financials, investors weigh a complex picture of global drug success, domestic pressures, and pipeline promise.

MGM Resorts moved its earnings date up, and now we know why. The gaming giant beat Wall Street estimates with powerful results from BetMGM and Macau.

With its Q4 results announcement imminent, specialty insurer Trisura is under scrutiny to prove it can sustain growth amid market pressures and investor concerns.

Facing a stock slump and operational woes, Clorox leaders must deliver a convincing turnaround plan at the upcoming CAGNY investor conference.

Canadian biotech Satellos Bioscience seeks a Nasdaq listing and a $50M public offering to advance its promising muscle regeneration drug for Duchenne.

Amid financial headwinds, specialty chemicals firm Orion S.A. will pitch its strategic pivot to the high-growth EV and sustainable materials markets.

Stablecoin giant Tether's $150M investment in Gold.com signals a new era, merging physical gold with blockchain to redefine asset ownership.

Following a massive acquisition, VSE Corp. prepares to outline its future growth and market strategy at two major February investor conferences.

Angel Oak Mortgage REIT declared a hefty $0.32 dividend, boasting a 14% yield. But can its earnings sustain the payout in the evolving non-QM market?

As Vinci Compass preps its full-year 2025 results, investors watch for signs of strength in Latin America's burgeoning alternative asset market.

AI-powered reAlpha has launched a new platform to unify the fragmented homebuying journey. Can its integrated approach truly simplify the process for buyers?

As Churchill Capital XI's shares and warrants begin separate trading, what does this mean for investors and the hunt for Michael Klein's next big deal?

With a new focus on eye disease and fresh funding, Surrozen will present its novel Wnt-based pipeline to investors. What's at stake for the future of sight?

After a blockbuster IPO raised nearly $300 million, dermatologist-founded Veradermics is poised to challenge the hair loss market with its new oral pill.